News
FDA rushed out agency-wide AI tool—it’s not going well
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't connected to the Internet or the FDA's internal system, and has problems uploading documents and allowing users to submit questions.
The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback